ADPT
Price
$19.34
Change
+$2.11 (+12.25%)
Updated
Jun 24 closing price
Capitalization
3.1B
41 days until earnings call
Intraday BUY SELL Signals
LYEL
Price
$13.00
Change
+$0.37 (+2.93%)
Updated
Jun 24 closing price
Capitalization
303.11M
48 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADPT vs LYEL

ADPT vs LYEL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ADPT vs. LYEL commentary
Jun 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADPT is a StrongBuy and LYEL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2026
Stock price -- (ADPT: $19.34 vs. LYEL: $12.99)
Brand notoriety: ADPT: Notable vs. LYEL: Not notable
ADPT represents the Medical Specialties, while LYEL is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADPT: 227% vs. LYEL: 128%
Market capitalization -- ADPT: $3.1B vs. LYEL: $303.11M
ADPT [@Medical Specialties] is valued at $3.1B. LYEL’s [@Biotechnology] market capitalization is $303.11M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $120.61B to $0. The average market capitalization across the [@Medical Specialties] industry is $16.16B. The average market capitalization across the [@Biotechnology] industry is $2.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADPT’s FA Score shows that 0 FA rating(s) are green whileLYEL’s FA Score has 0 green FA rating(s).

  • ADPT’s FA Score: 0 green, 5 red.
  • LYEL’s FA Score: 0 green, 5 red.
According to our system of comparison, ADPT is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADPT’s TA Score shows that 6 TA indicator(s) are bullish while LYEL’s TA Score has 6 bullish TA indicator(s).

  • ADPT’s TA Score: 6 bullish, 4 bearish.
  • LYEL’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, LYEL is a better buy in the short-term than ADPT.

Price Growth

ADPT (@Medical Specialties) experienced а +15.26% price change this week, while LYEL (@Biotechnology) price change was +3.75% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +7.51%. For the same industry, the average monthly price growth was +8.61%, and the average quarterly price growth was +1.13%.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.42%. For the same industry, the average monthly price growth was +1.98%, and the average quarterly price growth was +1906.15%.

Reported Earning Dates

ADPT is expected to report earnings on Aug 05, 2026.

LYEL is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Medical Specialties (+7.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Biotechnology (+3.42% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADPT($3.1B) has a higher market cap than LYEL($303M). ADPT YTD gains are higher at: 19.089 vs. LYEL (-57.797). ADPT has higher annual earnings (EBITDA): -20.94M vs. LYEL (-178.09M). LYEL has more cash in the bank: 254M vs. ADPT (218M). LYEL has less debt than ADPT: LYEL (39.5M) vs ADPT (77.6M). ADPT has higher revenues than LYEL: ADPT (295M) vs LYEL (31K).
ADPTLYELADPT / LYEL
Capitalization3.1B303M1,021%
EBITDA-20.94M-178.09M12%
Gain YTD19.089-57.797-33%
P/E RatioN/AN/A-
Revenue295M31K951,613%
Total Cash218M254M86%
Total Debt77.6M39.5M196%
FUNDAMENTALS RATINGS
ADPT: Fundamental Ratings
ADPT
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADPTLYEL
RSI
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 22 days ago
82%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 23 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ADPT
Daily Signal:
Gain/Loss:
LYEL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MXXIX65.19N/A
N/A
Marsico Midcap Growth Focus Fund
EDIAX12.30N/A
N/A
Eaton Vance Global Income Builder A
FSTRX38.71N/A
N/A
Federated Hermes MDT Large Cap Value A
MOJCX17.24N/A
N/A
DF Tactical Momentum Fund C
MAIIX21.01N/A
N/A
iShares MSCI EAFE Intl Idx Instl

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
+2.85%
VCYT - LYEL
46%
Loosely correlated
+5.52%
ALLO - LYEL
40%
Loosely correlated
-1.21%
RKTO - LYEL
40%
Loosely correlated
-2.91%
VYGR - LYEL
38%
Loosely correlated
-0.54%
BEAM - LYEL
38%
Loosely correlated
+2.02%
More